title: The optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: chasing a mirage.
authors.affiliation: Scripps Clinic and Scripps Translational Science Institute, La Jolla, California. Electronic address: price.matthew@scrippshealth.org.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Price
mesh_terms: D054855:Drug-Eluting Stents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000209:etiology*; D013927:Thrombosis / Q000209:etiology*
chemical_list: D010975:Platelet Aggregation Inhibitors
keywords: P2Y(12) inhibitor; drug-eluting stent(s); dual antiplatelet therapy; thienopyridine